A Maestri

985 total citations
30 papers, 581 citations indexed

About

A Maestri is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, A Maestri has authored 30 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in A Maestri's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Cancer Treatment and Pharmacology (5 papers). A Maestri is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Cancer Treatment and Pharmacology (5 papers). A Maestri collaborates with scholars based in Italy, United Kingdom and Uganda. A Maestri's co-authors include Alessandra Santini, Luigi Grassi, P Malacarne, Lucio Crinò, M. Boccalon, Monica Indelli, Claudio Zanna, Sante Cundari, Enrico Cortesi and Vincenzo Scorcia and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

A Maestri

27 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Maestri Italy 12 328 192 106 99 60 30 581
Kate Webber Australia 15 404 1.2× 136 0.7× 136 1.3× 88 0.9× 68 1.1× 47 669
H. Irving Pierce United States 14 244 0.7× 162 0.8× 95 0.9× 58 0.6× 56 0.9× 22 834
Desirée Jones United States 14 306 0.9× 88 0.5× 56 0.5× 98 1.0× 21 0.3× 31 594
Andrea Saini Italy 17 273 0.8× 244 1.3× 76 0.7× 58 0.6× 17 0.3× 29 840
Nancy L. Vaught United States 7 333 1.0× 186 1.0× 55 0.5× 76 0.8× 17 0.3× 8 706
Verena Meraner Austria 15 403 1.2× 131 0.7× 181 1.7× 103 1.0× 91 1.5× 25 701
Satoru Iwase Japan 14 330 1.0× 151 0.8× 95 0.9× 112 1.1× 7 0.1× 44 693
Margaret Barton‐Burke United States 13 325 1.0× 112 0.6× 75 0.7× 94 0.9× 33 0.6× 51 631
Pleun J. de Raaf Netherlands 8 362 1.1× 130 0.7× 190 1.8× 122 1.2× 16 0.3× 10 575
H. Sommer Germany 15 403 1.2× 154 0.8× 47 0.4× 57 0.6× 44 0.7× 75 784

Countries citing papers authored by A Maestri

Since Specialization
Citations

This map shows the geographic impact of A Maestri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Maestri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Maestri more than expected).

Fields of papers citing papers by A Maestri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Maestri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Maestri. The network helps show where A Maestri may publish in the future.

Co-authorship network of co-authors of A Maestri

This figure shows the co-authorship network connecting the top 25 collaborators of A Maestri. A scholar is included among the top collaborators of A Maestri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Maestri. A Maestri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tateo, Valentina, Costantino Ricci, Elisa Tassinari, et al.. (2025). Pathological and Clinical Implications of Tumor Microenvironment Evaluated With Multiplex Immunohistochemistry in Testicular Embryonal Carcinoma. Clinical Genitourinary Cancer. 23(6). 102444–102444.
2.
Giannaccare, Giuseppe, Federico Bernabei, Martina Angi, et al.. (2021). Iatrogenic Ocular Surface Diseases Occurring during and/or after Different Treatments for Ocular Tumours. Cancers. 13(8). 1933–1933. 6 indexed citations
3.
Brandes, Alba A., Andrea Ardizzoni, Fabrizio Artioli, et al.. (2020). Fighting Cancer in Coronavirus Disease Era: Organization of Work in Medical Oncology Departments in Emilia Romagna Region of Italy. Future Oncology. 16(20). 1433–1439. 11 indexed citations
4.
Bersanelli, Melissa, Elisabetta Gambale, Alessio Cortellini, et al.. (2017). Influenza vaccine indication during anticancer therapy with immune-checkpoint inhibitors: A transversal challenge for patient’s counselling – preliminary analysis of the INVIDIa study. Annals of Oncology. 28. xi17–xi17. 3 indexed citations
5.
Franceschi, Enrico, A. Tosoni, R. Agati, et al.. (2010). Efficacy of tailored treatment for high- and low-risk medulloblastoma in adults: A large prospective phase II trial.. Journal of Clinical Oncology. 28(15_suppl). 2003–2003. 10 indexed citations
6.
Franceschi, Enrico, A. Tosoni, V. Blatt, et al.. (2007). 2518 POSTER Prolonged maintenance chemotherapy with Temozolomide (TMZ) after concomitant treatment in newly diagnosed GBM: safety profile. European Journal of Cancer Supplements. 5(4). 232–233. 1 indexed citations
7.
Novello, Silvia, Adrian Kielhorn, Giovanni Selvaggi, et al.. (2005). Cost-minimisation analysis comparing gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of advanced non-small cell lung cancer in Italy. Lung Cancer. 48(3). 379–387. 18 indexed citations
8.
Cappuzzo, Federico, Giovanni Selvaggi, Vanesa Gregorc, et al.. (2003). Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA‐bulky N2 and Stage IIIB nonsmall cell lung carcinoma. Cancer. 98(1). 128–134. 34 indexed citations
9.
Marucci, Gianluca, et al.. (2001). Gemcitabine-associated CD8+ CD30+ pseudolymphoma.. British Journal of Dermatology. 145(4). 650–652. 14 indexed citations
10.
Scagliotti, Giorgio V., Filippo de Marinis, Maurizio Tonato, et al.. (2001). Phase II trial of BBR3464, a novel, bifunctional platinum analog, in advanced but favorable out-come, Non Small Cell Lung Cancer patients. European Journal of Cancer. 37. S52–S52. 3 indexed citations
11.
Marucci, Gianluca, et al.. (2001). Gemcitabine-associated CD8+ CD30+ pseudolymphoma.. British Journal of Dermatology. 145(4). 650–652. 7 indexed citations
12.
Grassi, Luigi, et al.. (1997). Depression, psychosocial variables and occurrence of life events among patients with cancer. Journal of Affective Disorders. 44(1). 21–30. 62 indexed citations
13.
14.
Grassi, Luigi, et al.. (1996). Depressive symptoms and quality of life in home-care-assisted cancer patients. Journal of Pain and Symptom Management. 12(5). 300–307. 134 indexed citations
15.
Malacarne, P, Alessandra Santini, & A Maestri. (1996). Response of Brain Metastases from Lung Cancer to Systemic Chemotherapy with Carboplatin and Etoposide. Oncology. 53(3). 210–213. 38 indexed citations
16.
Sartori, Sergio, Lucio Trevisani, Davide Tassinari, et al.. (1996). Cost analysis of long-term feeding by percutaneous endoscopic gastrostomy in cancer patients in an Italian health district. Supportive Care in Cancer. 4(1). 21–26. 21 indexed citations
17.
Manfredini, Roberto, Salmi Razali, Massimo Gallerani, et al.. (1994). Haematological Profile in Cancer Patients: Analysis of Circadian Pattern. Journal of International Medical Research. 22(6). 343–349. 6 indexed citations
18.
Sartori, Sergio, Ida Broman Nielsen, Davide Tassinari, A Maestri, & Vincenzo Abbasciano. (1991). Intracellular magnesium concentrations and acute anthracycline-induced cardiotoxicity. British Journal of Cancer. 64(4). 785–787. 4 indexed citations
19.
Sartori, Sergio, et al.. (1991). Acute Gastroduodenal Mucosal Injury after Cisplatin plus Etoposide Chemotherapy. Oncology. 48(5). 356–361. 22 indexed citations
20.
Neri, Flavia, et al.. (1961). Angiography study of renal circulation in dogs treated with synthetic hypertensin.. PubMed. 3. 221–34. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kate Webber Breakdown of academic impact, for papers by H. Irving Pierce Breakdown of academic impact, for papers by Desirée Jones Breakdown of academic impact, for papers by Andrea Saini Breakdown of academic impact, for papers by Nancy L. Vaught Breakdown of academic impact, for papers by Verena Meraner Breakdown of academic impact, for papers by Satoru Iwase Breakdown of academic impact, for papers by Margaret Barton‐Burke Breakdown of academic impact, for papers by Pleun J. de Raaf Breakdown of academic impact, for papers by H. Sommer
Rankless by CCL
2026